Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting complement in neurodegeneration: challenges, risks, and strategies
Wioleta M. Zelek, B. Paul Morgan
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 8, pp. 615-628
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

A guide to complement biology, pathology and therapeutic opportunity
Dimitrios C. Mastellos, George Hajishengallis, John D. Lambris
Nature reviews. Immunology (2023) Vol. 24, Iss. 2, pp. 118-141
Closed Access | Times Cited: 104
Complement in the Brain: Contributions to Neuroprotection, Neuronal Plasticity, and Neuroinflammation
Suzanne S. Bohlson, Andrea J. Tenner
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 431-452
Open Access | Times Cited: 47
C3‐dependent effector functions of complement
Alessandra Zarantonello, Margot Revel, Anne Grünenwald, et al.
Immunological Reviews (2022) Vol. 313, Iss. 1, pp. 120-138
Open Access | Times Cited: 59
Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models
Sarah M. Carpanini, Megan Torvell, Ryan J. Bevan, et al.
Acta Neuropathologica Communications (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 44
Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases: an international mixed methods study
Melanie Sloan, Chris Wincup, Rupert Harwood, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 5, pp. 1259-1272
Open Access | Times Cited: 19
The complement system in neurodegenerative diseases
Jacqui Nimmo, Robert A. J. Byrne, Nikoleta Daskoulidou, et al.
Clinical Science (2024) Vol. 138, Iss. 6, pp. 387-412
Open Access | Times Cited: 7
The complement system in neurodegenerative and inflammatory diseases of the central nervous system
Luciana Negro-Demontel, Adam F. Maleki, Daniel S. Reich, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 6
Complement‐targeted therapeutics: Are we there yet, or just getting started?
Daniel Ricklin
European Journal of Immunology (2024) Vol. 54, Iss. 12
Open Access | Times Cited: 5
Low‐molecular weight inhibitors of the alternative complement pathway
Anna Schubart, Stefanie Flohr, Tobias Junt, et al.
Immunological Reviews (2022) Vol. 313, Iss. 1, pp. 339-357
Open Access | Times Cited: 21
Targeting terminal pathway reduces brain complement activation, amyloid load and synapse loss, and improves cognition in a mouse model of dementia
Wioleta M. Zelek, Ryan J. Bevan, B. Paul Morgan
Brain Behavior and Immunity (2024) Vol. 118, pp. 355-363
Open Access | Times Cited: 4
Brain-penetrant complement inhibition mitigates neurodegeneration in an Alzheimer's disease mouse model
Wioleta M. Zelek, Ryan J. Bevan, Jacqui Nimmo, et al.
Brain (2024)
Open Access | Times Cited: 4
ROS-related nanoparticles for the management of Alzheimer’s disease: Wielding the double-edged sword
Yibin Yu, Qi Zhang, Yihao Guo, et al.
Chemical Engineering Journal (2025), pp. 161784-161784
Closed Access
Knowing the enemy: strategic targeting of complement to treat Alzheimer disease
Andrea J. Tenner, Tiffany J. Petrisko
Nature Reviews Neurology (2025)
Closed Access
Neuroimmune crosstalk in chronic neuroinflammation: microglial interactions and immune modulation
Ludmila Müller, Svetlana Di Benedetto
Frontiers in Cellular Neuroscience (2025) Vol. 19
Open Access
Exploring the Potential of Aptamers in Targeting Neuroinflammation and Neurodegenerative Disorders: Opportunities and Challenges
Anna Hau-Yee Kong, Aston Jiaxi Wu, Olivia Ka-Yi Ho, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11780-11780
Open Access | Times Cited: 8
Free complement and complement containing extracellular vesicles as potential biomarkers for neuroinflammatory and neurodegenerative disorders
Marlies Burgelman, P Dujardin, Charysse Vandendriessche, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 7
Therapeutic Targets in Innate Immunity to Tackle Alzheimer’s Disease
Maria L. Serradas, Yingying Ding, Paula Martorell, et al.
Cells (2024) Vol. 13, Iss. 17, pp. 1426-1426
Open Access | Times Cited: 2
Hallmarks of aging in age-related macular degeneration and age-related neurological disorders: novel insights into common mechanisms and clinical relevance
Stela Vujosevic, Celeste Limoli, Igor Kozak
Eye (2024)
Closed Access | Times Cited: 2
The activation of complement C5a-C5aR1 axis in astrocytes facilitates the neuropathogenesis due to EV-A71 infection by upregulating CXCL1
Peiyu Zhu, Wangquan Ji, Dong Li, et al.
Journal of Virology (2024) Vol. 99, Iss. 1
Open Access | Times Cited: 2
The case for complement component 5 as a target in neurodegenerative disease
Amelia Stennett, Kallie Friston, Claire L. Harris, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 2, pp. 97-109
Open Access | Times Cited: 4
The Hidden Hand in White Matter: Pericytes and the Puzzle of Demyelination
Siddharth Raj, Priyabrata Sarangi, Divya Goyal, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 10, pp. 2912-2923
Closed Access | Times Cited: 1
The molecular pathogenesis of achalasia: a paired lower esophageal sphincter muscle and serum 4D label-free proteomic study
Songfeng Chen, Xiangbin Xing, Xun Hou, et al.
Gastroenterology report (2022) Vol. 11
Open Access | Times Cited: 6
Regulatable Complement Inhibition of the Alternative Pathway Mitigates Wet Age-Related Macular Degeneration Pathology in a Mouse Model
Nathaniel Parsons, A. Balasubramaniam, Bärbel Rohrer
Translational Vision Science & Technology (2023) Vol. 12, Iss. 7, pp. 17-17
Open Access | Times Cited: 2
The potential application of complement inhibitors-loaded nanosystem for autoimmune diseases via regulation immune balance
Yaya Wei, Jueshuo Guo, Tingting Meng, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 5, pp. 485-498
Closed Access
Plant derived bioactive compounds for the treatment of neurodegeneration and neuroimmune disorders associated with the complement system
Jeyaparthasarathy Narayanaperumal, Ganesh Gopal
Exploration of Immunology (2024) Vol. 4, Iss. 4, pp. 744-769
Open Access
Page 1 - Next Page

Scroll to top